ストックスクリーナーアプリを入手
273.73
0.99%
2.68
アフターアワーズ：
273.73
前日終値:
$271.05
開ける：
$271.01
24時間の取引高:
1.17M
Relative Volume:
1.20
時価総額：
$40.08B
収益：
$5.15B
当期純損益:
$1.40B
株価収益率:
28.78
EPS:
9.51
ネットキャッシュフロー:
$1.65B
1週間 パフォーマンス:
-0.68%
1か月 パフォーマンス:
-0.28%
6か月 パフォーマンス:
+22.28%
1年 パフォーマンス:
+12.13%
1日の値動き範囲:
$270.74
$275.70
1週間の範囲:
$264.14
$277.43
52週間の値動き範囲:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
RMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-18 | 開始されました | Citigroup | Buy |
| 2025-09-02 | アップグレード | CLSA | Hold → Outperform |
| 2025-07-15 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 開始されました | Morgan Stanley | Overweight |
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
Archford Capital Strategies LLC Acquires Shares of 1,262 ResMed Inc. $RMD - MarketBeat
Will ResMed Inc. stock beat growth indexesCPI Data & Reliable Breakout Forecasts - newser.com
How sentiment analysis helps forecast ResMed Inc.Trade Ideas & Scalable Portfolio Growth Methods - newser.com
Wealth Enhancement Advisory Services LLC Has $1.65 Million Holdings in ResMed Inc. $RMD - MarketBeat
Is a relief rally coming for ResMed Inc. holders2025 Major Catalysts & Real-Time Sentiment Analysis - newser.com
Quantitative breakdown of ResMed Inc. recent moveJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
ASX 200 Value Spotlight: Mineral Resources vs ResMed Debate - Kalkine Media
Why ResMed could be one of the best shares on the ASX - MSN
What margin trends mean for ResMed Inc. stockWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Will ResMed Inc. (Common Stock) (RMEA) stock benefit from mergersMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
Published on: 2025-09-29 07:29:21 - newser.com
The Bull Case For ResMed (RMD) Could Change Following U.S. Probe Into Medical Device Imports - Yahoo Finance
How ResMed Inc. (Common Stock) (RMEA) stock benefits from digital adoption2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com
ResMed Inc. (RMD) Stock Analysis: Exploring a 8.52% Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
ResMed Inc. (RMD) Stock Analysis: Healthcare Innovator With 8.52% Upside Potential - DirectorsTalk Interviews
How supply shortages influence ResMed Inc. (Common Stock) (RMEA) stockWeekly Risk Summary & High Accuracy Buy Signal Tips - newser.com
Can ResMed Inc. stock sustain revenue momentumMarket Growth Summary & Weekly Setup with High ROI Potential - newser.com
Addenda Capital Inc. Acquires 1,113 Shares of ResMed Inc. $RMD - MarketBeat
Charles Schwab Trust Co Makes New $425,000 Investment in ResMed Inc. $RMD - MarketBeat
Does ResMed Inc. (RME) stock trade below intrinsic valueMarket Movers & Safe Entry Point Alerts - newser.com
ResMed Inc. $RMD Shares Sold by Congress Asset Management Co. - MarketBeat
How strong is ResMed Inc. (RME) stock earnings growthWeekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
Intraday pattern recognizer results for ResMed Inc.Weekly Trend Summary & Safe Capital Investment Plans - newser.com
Will ResMed Inc. stock attract long term capital inflowsJuly 2025 Sector Moves & High Win Rate Trade Tips - newser.com
Public Employees Retirement System of Ohio Grows Stake in ResMed Inc. $RMD - MarketBeat
Novem Group Lowers Stock Position in ResMed Inc. $RMD - MarketBeat
Patton Fund Management Inc. Has $2.46 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc.'s (NYSE:RMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - 富途牛牛
Why retail investors favor ResMed Inc. stockEarnings Recap Report & Real-Time Volume Surge Alerts - The British Mountaineering Council
ST Germain D J Co. Inc. Has $24.65 Million Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by True North Advisors LLC - MarketBeat
Park Avenue Securities LLC Invests $1.39 Million in ResMed Inc. $RMD - MarketBeat
Dakota Wealth Management Buys 3,014 Shares of ResMed Inc. $RMD - MarketBeat
The Future of Home Oxygen TherapyThe New Technological Advancements from Everflo and ResMed That Are Changing the Game - MarketScreener
ResMed, Inspire Medical fall after Lilly's Zepbound gains sleep apnea indication - MSN
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know - Yahoo Finance
Zacks.com featured highlights include GE Aerospace, ResMed, Vertiv and National Fuel Gas - Yahoo Finance
Diversified Trust Co Acquires New Position in ResMed Inc. $RMD - MarketBeat
ResMed '2030 Strategy' aims for high-single-digit revenue growth. - MSN
ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years - Yahoo Finance
BofA Securities Maintains ResMed(RMD.US) With Buy Rating, Maintains Target Price $300 - 富途牛牛
BDF Gestion Sells 1,159 Shares of ResMed Inc. $RMD - MarketBeat
Yarbrough Capital LLC Grows Stake in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by IFM Investors Pty Ltd - MarketBeat
Assenagon Asset Management S.A. Purchases 28,801 Shares of ResMed Inc. $RMD - MarketBeat
ResMed targets 59-60% gross margins and expanded global reach for AirSense 11 - MSN
Transcript : ResMed Inc. Presents at Bank of America Global Healthcare Conference 2025, Sep-23-2025 12 - MarketScreener
ResMed (NYSE:RMD) Coverage Initiated by Analysts at Citigroup - MarketBeat
Swedbank AB Increases Stake in ResMed Inc. $RMD - MarketBeat
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
0.54%
大文字化:
|
ボリューム (24 時間):